Knockdown of PCK2 in DLBCL cells did not significantly affect cell growth in high glucose conditions; however, it remarkably inhibited cells proliferation and increased apoptosis in low glucose conditions. The gene discussed is PCK2; the disease is diffuse large B-cell lymphoma.